Vitamin C for slowing COPD progression
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether vitamin C, an antioxidant, can help slow the progression of COPD and improve prognosis. If you qualify, you may take vitamin C and have your lung health monitored over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have a COPD diagnosis that is moderate to very severe (grades 2 to 4).
- You have not had a COPD flare-up or a respiratory infection in the past 4 weeks.
- You are not currently taking vitamin C supplements (or can stop them for the study).
- You do not have other major lung diseases, unstable heart disease, active cancer, poorly controlled diabetes, or a history of kidney stones.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether increasing omega-3 (from diet and/or supplements) helps people with COPD. It enrolls people with low omega-3 intake and asks them to follow a specific dietary plan during the study.
This study tests whether adding silymarin (a herbal supplement from milk thistle) to your regular COPD treatment can improve your lung function, reduce stress in your body, and help you feel better day-to-day.
This study tests whether taking a probiotic can improve symptoms, lung function, and inflammation in people with COPD. It is for adults with stable COPD who have not had a flare-up or treatment change in the last two months.
This trial tests whether eating aronia berries (black chokeberries) can help reduce inflammation in people with COPD. It may offer a natural way to manage COPD symptoms.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This study follows people with COPD (chronic lung disease) over many years to better understand the condition. It may help doctors learn what factors predict worsening over time.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.